Skip to content
Screener

Baxter International BAX Business Combination, Contingent Consideration, Liability

Business Combination, Contingent Consideration, Liability at other companies

Medline, Inc. logo
Medline, Inc.MDLN
$29M

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$13.96B+20.8%
Enterprise value$12.17B+20.5%
P/S1.2×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiability.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
(in millions) / Assets / Foreign exchange contractsBalance as of March 31, 2026 / $Balance as of March 31, 2026 / —Basis of fair value measurement / Quoted prices in active markets for identical assets(Level 1) / $Basis of fair value measurement / Quoted prices in active markets for identical assets(Level 1) / —Basis of fair value measurement / Significant otherobservable inputs(Level 2) / $Basis of fair value measurement / Significant otherobservable inputs(Level 2) / —Basis of fair value measurement / Significantunobservable inputs(Level 3) / $Basis of fair value measurement / Significantunobservable inputs(Level 3) / —
Available-for-sale debt securities11
Marketable equity securities1111
Total$$12$$11$$$1
Liabilities
Foreign exchange contracts$$2$$$2$
Contingent payments related to acquisitions77
Indemnifications related to Kidney Care separation15353
Total$$62$$$2$$60

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's business combination, contingent consideration, liability?
Baxter International (BAX) reported business combination, contingent consideration, liability of $7M in Q1 2026.

Ask your AI about Baxter International's business combination, contingent consideration, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude